Chandler, AZ, United States of America

Rajesh Wakaskar

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Chandler, AZ (US) (2018 - 2021)
  • Watertown, MA (US) (2023)

Company Filing History:


Years Active: 2018-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Rajesh Wakaskar: Pioneering Pharmaceutical Stabilization

Introduction

Rajesh Wakaskar, an accomplished inventor based in Chandler, AZ, has made significant contributions to the pharmaceutical industry. With a total of five patents under his name, Wakaskar's innovative work focuses on methods to stabilize essential medications.

Latest Patents

Among his notable inventions, Rajesh holds patents for methods of stabilizing epinephrine. These patents detail a comprehensive approach that includes steps such as filling a container, capping it, assembling the device, and placing the completed assembly into a secondary packaging system. This invention aims to enhance the stability and efficacy of epinephrine formulations, ensuring better preservation and delivery to patients in need.

Career Highlights

Wakaskar's career has included significant roles at various pharmaceutical companies. He has worked for Hikma Pharmaceuticals USA Inc. and Insys Development Company, Inc., where he has utilized his expertise to advance drug formulation and delivery systems. His experience in these companies highlights his commitment to improving pharmaceutical technologies.

Collaborations

Throughout his career, Rajesh has collaborated with talented professionals, including coworkers Thrimoorthy Potta and Venkat R. Goskonda. These collaborative efforts have allowed him to leverage diverse expertise and contribute to groundbreaking innovations in the pharmaceutical field.

Conclusion

Rajesh Wakaskar exemplifies the spirit of innovation in the pharmaceutical industry. With his valuable patents and collaborative approach, he continues to play a vital role in enhancing the stability of essential medications, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…